Expertise in
18
conditions

Dr. Christopher C. Croot

Hematology
Pikeville Medical Center Inc
911 Bypass Rd, 
Pikeville, KY 
Accepting New Patients
Expertise in
18
conditions
Pikeville Medical Center Inc
911 Bypass Rd, 
Pikeville, KY 

Overview

Christopher Croot is a Hematologist practicing medicine in Pikeville, Kentucky.

Dr. Croot is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Anemia, ALK-Positive Non-Small Cell Lung Cancer, and Non-Hodgkin Lymphoma.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 3 clinical trials. Dr. Croot is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in MS

Hospital Affiliations

Pikeville Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Pikeville Medical Center Inc
911 Bypass Rd, Pikeville, KY 41501

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (AMBER)
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (AMBER)
Enrollment Status: Active_not_recruiting
Publish Date: October 28, 2025
Intervention Type: Drug
Study Drugs: TSR-022, Nivolumab, TSR-042, TSR-033, Docetaxel
Study Phase: Phase 1
Phase 2 Study of Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib in Patients With Untreated Extensive-Stage Small Cell Lung Cancer (SCLC)
Phase 2 Study of Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib in Patients With Untreated Extensive-Stage Small Cell Lung Cancer (SCLC)
Enrollment Status: Completed
Publish Date: September 25, 2025
Intervention Type: Drug
Study Drugs: Trilaciclib, Carboplatin, Etoposide, Atezolizumab
Study Phase: Phase 2
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Enrollment Status: Completed
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Elacestrant, Standard of Care
Study Phase: Phase 3
View 2 Less Clinical Trials

1 Total Publications

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.
Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.
Journal: The Lancet. Oncology
Published: March 19, 2013
Similar Doctors
Expertise in
21
conditions
Dr. Vickie G. Morgan
Hematology | Oncology
Expertise in
21
conditions
Dr. Vickie G. Morgan
Hematology | Oncology
Referral may be required

Pikeville Medical Center Inc

911 Bypass Rd, 
Pikeville, KY 
 (0.1 miles away)
606-218-3500
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Vickie Morgan is a Hematologist and an Oncologist practicing medicine in Pikeville, Kentucky. Dr. Morgan is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Breast Cancer, and Small Cell Lung Cancer (SCLC). Dr. Morgan is currently accepting new patients.

Expertise in
23
conditions
Dr. Waris A. Waris
Hematology | Oncology
Expertise in
23
conditions
Dr. Waris A. Waris
Hematology | Oncology
Referral may be required

Logan Regional Physician Practices

1690 Holden Rd Fl 1, 
Logan, WV 
 (39.1 miles away)
304-239-8070
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Waris Waris is a Hematologist and an Oncologist practicing medicine in Logan, West Virginia. Dr. Waris is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, Anemia, and Endoscopy. Dr. Waris is currently accepting new patients.

Expertise in
15
conditions
Dr. Kenneth F. More
Hematology | Oncology
Expertise in
15
conditions
Dr. Kenneth F. More
Hematology | Oncology
Referral may be required
Before you request

Regional Cancer Center At JMH

16000 Johnston Memorial Dr, 
Abingdon, VA 
 (61.9 miles away)
276-258-1880
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kenneth More is a Hematologist and an Oncologist practicing medicine in Abingdon, Virginia. Dr. More is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. More is board certified in American Board Of Internal Medicine. Dr. More is currently accepting new patients.

Frequently Asked Questions about Dr. Christopher C. Croot

How do I make an appointment with Dr. Christopher C. Croot?

You can book an appointment with Dr. Christopher C. Croot by calling their office at 606-430-2212. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Christopher C. Croot a top-rated expert for Thrombocytopenia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christopher C. Croot is classified as an Distinguished expert for Thrombocytopenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Christopher C. Croot specialize in?

While Dr. Christopher C. Croot is a Hematology, they have specific expertise in Thrombocytopenia, Anemia, and ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Christopher C. Croot participate in research or clinical trials?

Yes. Dr. Christopher C. Croot has published 1 articles and abstracts on conditions like Thrombocytopenia. You can view a list of Dr. Christopher C. Croot's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Christopher C. Croot accept my insurance?

Dr. Christopher C. Croot accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 606-430-2212 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Croot's expertise for a condition
ConditionClose
    View All 17 Advanced Conditions
    View All 59 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile